Literature DB >> 1900413

Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine.

P L Bernsen1, F J Gabreëls, W Ruitenbeek, R C Sengers, A M Stadhouders, W O Renier.   

Abstract

We describe a 6-year-old boy who presented with progressive muscle weakness. Additional investigations revealed the existence of a myopathy and a pure motor neuropathy. Biochemical studies in muscle tissue showed a defect of NADH dehydrogenase (complex I). The patient dramatically improved on treatment with riboflavin and L-carnitine. Seven months after the start of the treatment, complex I activity was determined again and appeared to be normalized. Normalization of the enzymatic defect at this level has not been reported before. We provide a survey of nine patients with pure myopathy, associated with complex I deficiency and onset of symptoms in childhood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900413     DOI: 10.1001/archneur.1991.00530150106028

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

Review 1.  Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex.

Authors:  F J Trijbels; W Ruitenbeek; M Huizing; U Wendel; J A Smeitink; R C Sengers
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

2.  Metabolic interventions against complex I deficiency in MELAS syndrome.

Authors:  K Majamaa; H Rusanen; A Remes; I E Hassinen
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 3.  A scientific rationale for protective therapy in Parkinson's disease.

Authors:  C W Olanow
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  An unusual patient with the neonatal Marfan phenotype and mitochondrial complex I deficiency.

Authors:  J Christodoulou; R Petrova-Benedict; B H Robinson; V Jay; J T Clarke
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

5.  Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.

Authors:  R Artuch; M A Vilaseca; M Pineda
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

6.  Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.

Authors:  G Kurlemann; I Paetzke; H Möller; H Masur; G Schuierer; J Weglage; H G Koch
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

7.  Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases.

Authors:  J Panetta; L J Smith; A Boneh
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 8.  Current and Emerging Clinical Treatment in Mitochondrial Disease.

Authors:  Rory J Tinker; Albert Z Lim; Renae J Stefanetti; Robert McFarland
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 9.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.